Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    October 2017
  1. PATEL CG, Michaelson E, Chen YH, Silver B, et al
    Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2017 Oct 5. pii: S0360-3016(17)33954.
    PubMed     Text format     Abstract available


  2. NANDA R, Flampouri S, Mendenhall NP, Indelicato DJ, et al
    Pulmonary Toxicity Following Proton Therapy for Thoracic Lymphoma.
    Int J Radiat Oncol Biol Phys. 2017;99:494-497.
    PubMed     Text format    


    September 2017
  3. ARISTOPHANOUS M, Chi PM, Kao J, Williamson R, et al
    Deep-Inspiration Breath-Hold Intensity Modulated Radiation Therapy to the Mediastinum for Lymphoma Patients: Setup Uncertainties and Margins.
    Int J Radiat Oncol Biol Phys. 2017 Sep 25. pii: S0360-3016(17)33936.
    PubMed     Text format     Abstract available


  4. TSENG YD, Cutter DJ, Plastaras JP, Parikh RR, et al
    Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
    Int J Radiat Oncol Biol Phys. 2017 Sep 21. pii: S0360-3016(17)30901.
    PubMed     Text format    


  5. WILKE C, Cao Q, Dusenbery KE, Bachanova V, et al
    Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2017;99:94-102.
    PubMed     Text format     Abstract available


  6. CHANG JY, Zhang X, Knopf A, Li H, et al
    Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee.
    Int J Radiat Oncol Biol Phys. 2017;99:41-50.
    PubMed     Text format     Abstract available


    August 2017
  7. MELCHERS RC, Willemze R, Daniels LA, Neelis KJ, et al
    Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
    Int J Radiat Oncol Biol Phys. 2017 Aug 24. pii: S0360-3016(17)33721.
    PubMed     Text format     Abstract available


  8. HAHN E, Jiang H, Ng A, Bashir S, et al
    Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
    Int J Radiat Oncol Biol Phys. 2017;98:1116-1123.
    PubMed     Text format     Abstract available


    July 2017
  9. KRUL IM, Opstal-van Winden AWJ, Aleman BMP, Janus CPM, et al
    Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
    Int J Radiat Oncol Biol Phys. 2017 Jul 18. pii: S0360-3016(17)33598.
    PubMed     Text format     Abstract available


    June 2017
  10. MORRIS S, Scarisbrick J, Frew J, Irwin C, et al
    The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group.
    Int J Radiat Oncol Biol Phys. 2017 Jun 9. pii: S0360-3016(17)31003.
    PubMed     Text format     Abstract available


    April 2017
  11. RIMNER A, Lovie S, Hsu M, Chelius M, et al
    Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.
    Int J Radiat Oncol Biol Phys. 2017;97:1066-1076.
    PubMed     Text format     Abstract available


    February 2017
  12. MILGROM SA, Dong W, Akhtari M, Smith GL, et al
    Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score.
    Int J Radiat Oncol Biol Phys. 2017;97:333-338.
    PubMed     Text format     Abstract available


  13. EL-FAYECH C, Haddy N, Allodji RS, Veres C, et al
    Cerebrovascular Diseases in Childhood Cancer Survivors: Role of the Radiation Dose to Willis Circle Arteries.
    Int J Radiat Oncol Biol Phys. 2017;97:278-286.
    PubMed     Text format     Abstract available


    January 2017
  14. CONWAY JL, Connors JM, Tyldesley S, Savage KJ, et al
    Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2017;97:35-41.
    PubMed     Text format     Abstract available


    December 2016
  15. CHARPENTIER AM, Friedman DL, Wolden S, Schwartz C, et al
    Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.
    Int J Radiat Oncol Biol Phys. 2016;96:943-950.
    PubMed     Text format     Abstract available


    October 2016
  16. AKHTARI M, Reddy J, Dong W, Milgrom SA, et al
    Restratifying Early-Stage Hodgkin Lymphoma Patients Using Novel Functional Imaging Parameters.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  17. MILGROM SA, Dong W, Akhtari M, Smith GL, et al
    Postchemotherapy Positron Emission Tomography/Computed Tomography Scans in Early-Stage Hodgkin Lymphoma: Moving Beyond the Deauville 5-Point Scale.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  18. RAHMAN F, Brady JL, Dunn JT, Smith D, et al
    Consolidation Radiation Therapy Improves Outcome of Diffuse Large B-cell Lymphoma Independent of Pretreatment Prognosis or Response to Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  19. HOPPE BS, Hill-Kayser CE, Tseng YD, Flampouri S, et al
    The Use of Consolidative Proton Therapy After First-Line Therapy Among Patients With Hodgkin Lymphoma at Academic and Community Proton Centers.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  20. GRASS GD, Peacock J, Latifi K, Zhang GG, et al
    Spatial Patterns of Local Failure Following Chemotherapy in Hodgkin Lymphoma: Volume Reduction From Involved Site/Nodal Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  21. SMITH GL, Duvic M, Yehia ZA, Allen PK, et al
    Effectiveness of Very Low- and Low-Dose Radiation for Primary Cutaneous Anaplastic Large Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  22. FUNK RK, Blanchard MJ, Williamson EE, Young PM, et al
    A Prospective Pilot Study Evaluating Feasibility and Utility of ECG-gated CT Angiography for Coronary-Sparing Radiation Therapy Planning in Mediastinal Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  23. REDDY J, Gunther JR, Dabaja B, Akhtari M, et al
    Pretreatment Neutrophil/Lymphocyte Ratio Predicts Relapse in Stage I and II Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  24. YANG JC, Kumar A, Chapman KL, Constine LS, et al
    Brentuximab Vedotin and AVD Chemotherapy Followed by ISRT: A Safe Primary Treatment Regimen for Early-Stage, Unfavorable Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  25. GUNTHER JR, Fanale M, Reddy J, Akhtari M, et al
    Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  26. HO JC, Reddy J, Mazloom A, Allen PK, et al
    Radiation Therapy Improves Outcomes in Patients With Primary Testicular Diffuse Large B-cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  27. PINNIX CC, Yehia ZA, Qiao W, Milgrom SA, et al
    Utilization of Positron Emission Tomography/Computed Tomography Parameters to Identify Patients at Risk for Progression After Treatment With Dose-Adjusted R-EPOCH for Primary Mediastinal B-Cell Lymphoma (PMBCL).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  28. MANN JM, Wu X, Christos P, Nori D, et al
    Combined Modality Therapy for Early-Stage Grade 3 Follicular Lymphoma Improves Overall Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  29. MILGROM SA, Smith GL, Pinnix CC, Dong W, et al
    Prognostic Significance of the Postchemotherapy Positron Emission Tomography (PET)/Computed Tomography in Early-Stage Hodgkin Lymphoma: Can PET-Positive Patients Be Cured With Radiation Alone?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  30. HAQUE W, Tann AW, Szeja S, Butler EB, et al
    Changes in Treatment Patterns and Overall Survival for Early-Stage Diffuse Large B Cell Lymphoma in the United States After Rituximab: A Population-Based Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  31. YANG Y, Wu J, Wu T, Zhu SY, et al
    Optimizing Radiation Dose for Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  32. JHAVERI J, Danish H, Liu S, Flowers CR, et al
    Validation of Cutaneous Lymphoma International Prognostic Index (CLIPI) for Mycosis Fungoides and Sezary Syndrome.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  33. ABOU YEHIA Z, Dabaja B, Smith GL, Milgrom SA, et al
    Effectiveness of Radiation Treatment in Adult Patients With Mediastinal T Cell Lymphoblastic Leukemia/Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  34. ABUODEH YA, Ahmed KA, Echevarria M, Naghavi AO, et al
    Priming Radioimmunotherapy With External Beam Radiation in Patients With Relapsed Low-Grade Non-Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  35. FISCHER-VALUCK BW, Chundury A, Mazur TR, Green OL, et al
    Treatment of Gastric MALT Lymphoma Utilizing a Magnetic Resonance Image Guided Radiation Therapy (MR-IGRT) System: Evaluation of Interfractional Target Motion.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  36. VARGO J, Balasubramani GK, Beriwal S
    Alarming Rates of Omission or Inadequate Radiation Therapy in Extranodal Natural Killer T-cell Lymphoma Nasal Type in the United States.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  37. HAHN E, Ng A, Bashir S, Jiang H, et al
    Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Will Evaluating Dose to Coronary Arteries Improve Risk Estimates?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  38. HUYNH MA, Catalano PJ, Chen YH, Marcus KJ, et al
    Significant Reduction in Breast Cancer Risk as Long-Term Hodgkin Lymphoma Survivors Reach Menopausal Age.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  39. SHIN S, Silverman JS, Niranjan A, Bowden G, et al
    Radiosurgical Management of Primary Central Nervous System Lymphoma-A Multi-Institutional Experience.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  40. CHAUDHRY H, Souri S, Teckie S, Klein EE, et al
    Modeling the Effects of Deep Inspiratory Breath Hold (DIBH) Noncompliance on Lung and Heart Doses in Mediastinal Lymphoma Treatments.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  41. KUGELE ML, Edvardsson A, Alkner S, Kristensen I, et al
    Dosimetric Benefits From Deep Inspiration Proton and Photon Therapy for Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  42. MIKAMI R, Amar Z, Itonaga T, Shiraishi S, et al
    The Usefulness of Apparent Diffusion Coefficient Maps in the Evaluation of Radiation Therapy for Primary Central Nerve System Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  43. D'AVINO V, Conson M, Palma G, Liuzzi R, et al
    Normal Tissue Complication Probability Models for Radiation-Induced Hypothyroidism in Hodgkin Lymphoma Survivors.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  44. MADDEN NA, Marascio JA, Rabatic BM, Zaenger D, et al
    Trends in Utilization of Radiation in the Treatment of Pediatric Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  45. YANG K, Kim LJ, Suh JH, Murphy ES, et al
    Treatment Outcome of Adult Primary Spinal Cord Lymphoma: A Population-Based Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  46. FIGURA N, Flampouri S, Mendenhall NP, Morris CG, et al
    Impact of Prechemotherapy F-18 FDG Positron Emission Tomography/Computed Tomography Imaging on Radiation Field Design and Relapse Rates in Patients With Hodgkin Lymphoma Receiving Consolidative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  47. OGAWA Y, Shibamoto Y, Murai T, Manabe Y, et al
    What Are the Optimal Radiation Doses for Localized Lesions of Adult T-Cell Leukemia/Lymphoma?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  48. DANISH H, Cassidy RJ 3rd, Switchenko JM, Rai A, et al
    Consolidative Radiation for Early-Stage Diffuse Large B Cell Lymphoma After CHOP or RCHOP: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  49. LIU X, Xu LM, Yuan ZY, Wu J, et al
    Conditional Survival and Annual Hazard Rates of Early-Stage Extranodal Nasal-type NK/T-Cell Lymphoma Treated With Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  50. TISSEVERASINGHE SA, Samant R, Sabloff M, Xu Y, et al
    Total Body Irradiation in Relapsed Follicular Lymphoma: Outcomes and Early Toxicity.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  51. PLASTARAS JP, Vogel J, Elmongy H, Zeng C, et al
    First Clinical Report of Pencil Beam Scanned Proton Therapy for Mediastinal Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  52. ZHU S, Holtzman AL, Morris CG, Hoppe BS, et al
    Cardiac Events and Secondary Malignancies After Radiation Therapy With or Without Chemotherapy for Hodgkin Lymphoma: 20-Year Outcomes.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  53. ADEDUNTAN R, Francis S, Meyersohn N, Gallotto S, et al
    Comparison of Coronary Artery Calcification in Patients Who Received Proton Versus Photon Radiation for Treatment of Mediastinal Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  54. YOUN P, Cummings MA, Dhakal S, Burack WR, et al
    Prognostic Impact of Cell of Origin in Limited-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP With or Without Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  55. MILGROM SA, Jauhari S, Plastaras JP, Lukens JN, et al
    A Multi-institutional Analysis of Consolidative Radiation Therapy Following Autologous Transplantation for Relapsed/Refractory Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  56. BRADY JL, Attallah H, Mikhaeel NG
    Outcome of Low-Dose Palliative Radiation Therapy in Relapsed or Refractory High-Grade Non-Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  57. MODH A, McHargue CA, Lim H, Siddiqui F, et al
    Single-Fraction Radiation Therapy Provides Highly Effective Palliation for Cutaneous T-cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  58. LIE S, Ong CK, Tan J, Huang D, et al
    Abrogation of JAK/STAT Pathway in Radiosensitization of NK/T Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  59. BRADY JL, Begum R, Hartill C, Greener AG, et al
    Analysis of Factors Affecting Benefit from Deep Inspiration Breath Hold Technique in Mediastinal Radiation Therapy for Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  60. AZNAR MC, Maraldo MV, Girinski T, Berthelsen AK, et al
    Interobserver Delineation Uncertainty in Involved Node Therapy for Early-Stage Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  61. MILGROM SA, Cheah C, Pinnix CC, Smith GL, et al
    Acute and Late Toxicity of Bilateral Orbital Irradiation in the Management of Primary Intraocular Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  62. QI S, Lan S, Li-Ming X, Cao J, et al
    Primary Tumor Invasion as a Principal Prognostic Factor in Extranodal Nasal-type NK/T-Cell Lymphoma: A Multicenter Database Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  63. PINNIX CC, Abou Yehia Z, Smith GL, Milgrom SA, et al
    More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  64. RONG QL, Li YX, Zhu Y, Cao J, et al
    Treatment Outcome for Patients With Stage II Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  65. DENG XW, Li YX, Zhu Y, Cao J, et al
    Can Radiation Therapy Be Omitted in Patients With Early-Stage NK/T-Cell Lymphoma Who Achieved Complete Response to Chemotherapy? A Multicenter Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  66. VEGA RM, Ishaq O, Rene LM Sr, Amendola BE, et al
    A Novel, Pilot Curriculum for International Education of Lymphoma Management Employing e-Contouring.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


    September 2016
  67. CERIANI L, Martelli M, Gospodarowicz MK, Ricardi U, et al
    Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2016 Sep 28. pii: S0360-3016(16)33242.
    PubMed     Text format     Abstract available


  68. WU RY, Liu K, Wang WH, Jin J, et al
    Patterns of Primary Tumor Invasion and Regional Lymph Node Spread Based on Magnetic Resonance Imaging in Early-Stage Nasal NK/T-cell Lymphoma: Implications for Clinical Target Volume Definition and Prognostic Significance.
    Int J Radiat Oncol Biol Phys. 2016 Sep 17. pii: S0360-3016(16)33192.
    PubMed     Text format     Abstract available


    August 2016
  69. ABOU YEHIA Z, Mikhaeel GN, Smith G, Pinnix CC, et al
    Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?
    Int J Radiat Oncol Biol Phys. 2016 Aug 22. pii: S0360-3016(16)33103.
    PubMed     Text format     Abstract available


    June 2016
  70. XU YG, Qi SN, Wang SL, Liu YP, et al
    Dosimetric and Clinical Outcomes With Intensity Modulated Radiation Therapy After Chemotherapy for Patients With Early-Stage Diffuse Large B-cell Lymphoma of Waldeyer Ring.
    Int J Radiat Oncol Biol Phys. 2016 Jun 8. pii: S0360-3016(16)30279.
    PubMed     Text format     Abstract available


    May 2016
  71. DHAKAL S, Bates JE, Casulo C, Friedberg JW, et al
    Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse.
    Int J Radiat Oncol Biol Phys. 2016 May 27. pii: S0360-3016(16)30277.
    PubMed     Text format     Abstract available


  72. ELEY JG, Friedrich T, Homann KL, Howell RM, et al
    Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:279-86.
    PubMed     Text format     Abstract available


  73. DABAJA BS, Mikhaeel NG
    In the Battle Between Protons and Photons for Hematologic Malignancies, the Patient Must Win.
    Int J Radiat Oncol Biol Phys. 2016;95:43-5.
    PubMed     Text format    


    April 2016
  74. GUNTHER JR, Fanale MA, Reddy JP, Akhtari M, et al
    Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.
    Int J Radiat Oncol Biol Phys. 2016 Apr 13. pii: S0360-3016(16)30068.
    PubMed     Text format     Abstract available


    March 2016
  75. MILLION L, Yi EJ, Wu F, Von Eyben R, et al
    Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience.
    Int J Radiat Oncol Biol Phys. 2016 Mar 24. pii: S0360-3016(16)00335.
    PubMed     Text format     Abstract available


  76. RUELLA M, Filippi AR, Bruna R, Di Russo A, et al
    Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
    Int J Radiat Oncol Biol Phys. 2016;94:783-91.
    PubMed     Text format     Abstract available


  77. PINNIX CC
    Radiation Therapy for Diffuse Large B-Cell Lymphoma: Indications, Outcomes, and Controversies.
    Int J Radiat Oncol Biol Phys. 2016;94:641-4.
    PubMed     Text format    


  78. PIXBERG C, Koch R, Eich HT, Martinsson U, et al
    Acute Toxicity Grade 3 and 4 After Irradiation in Children and Adolescents: Results From the IPPARCA Collaboration.
    Int J Radiat Oncol Biol Phys. 2016;94:792-9.
    PubMed     Text format     Abstract available


    February 2016
  79. ZHOU R, Ng A, Constine LS, Stovall M, et al
    A Comparative Evaluation of Normal Tissue Doses for Patients Receiving Radiation Therapy for Hodgkin Lymphoma on the Childhood Cancer Survivor Study and Recent Children's Oncology Group Trials.
    Int J Radiat Oncol Biol Phys. 2016 Feb 4. pii: S0360-3016(16)00106.
    PubMed     Text format     Abstract available


  80. FITZGERALD TJ, Bishop-Jodoin M, Followill DS, Galvin J, et al
    Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;94:404-11.
    PubMed     Text format     Abstract available


    January 2016
  81. LIU X, Fang H, Tian Y, Wang WH, et al
    Intensity Modulated Radiation Therapy for Early-Stage Primary Gastric Diffuse Large B-Cell Lymphoma: Dosimetric Analysis, Clinical Outcome, and Quality of Life.
    Int J Radiat Oncol Biol Phys. 2016 Jan 22. pii: S0360-3016(16)00048.
    PubMed     Text format     Abstract available


  82. LOLLERT A, Gies C, Laudemann K, Faber J, et al
    Ultrasound Evaluation of Thyroid Gland Pathologies After Radiation Therapy and Chemotherapy to Treat Malignancy During Childhood.
    Int J Radiat Oncol Biol Phys. 2016;94:139-46.
    PubMed     Text format     Abstract available


    December 2015
  83. ELSAYAD K, Kriz J, Moustakis C, Scobioala S, et al
    Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2015;93:1077-1086.
    PubMed     Text format     Abstract available


    November 2015
  84. SIMONTACCHI G, Filippi AR, Ciammella P, Ricardi U, et al
    Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Reply to Adams and Kwee.
    Int J Radiat Oncol Biol Phys. 2015;93:725-6.
    PubMed     Text format    


  85. ADAMS HJ, Kwee TC
    Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Regard to Simontacchi et al.
    Int J Radiat Oncol Biol Phys. 2015;93:724-5.
    PubMed     Text format    


    October 2015
  86. CAHAN B, Chen YJ
    Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group: In Regard to Yahalom et al.
    Int J Radiat Oncol Biol Phys. 2015;93:471-2.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: